|
⚲
|
| Keyboard |
| Alvaro Guillem | |
|---|---|
| Firm | |
| Address | 181 Grand Avenue Suite 225 Southlake, TX 76092 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Onconano Medicine Inc | 021-378478 | Director | 68.4 M of 68.4 M |
||
| Nanoscope Therapeutics Inc | 021-371542 | Director | 12.8 M of 16.1 M |
||
| Renibus Therapeutics Inc | 021-349442 | Director | 34.6 M of 34.6 M |
||
| Onconano Medicine Inc | 021-308806 | Director | 33.9 M of 35.4 M |
||
| ZS Pharma Inc | 021-213340 | Executive Officer | 25.0 M of 25.0 M |
||
| ZS Pharma Inc | 021-185980 | Executive Officer | 27.6 M of 46.0 M |
||
| ZS Pharma Inc | 021-169143 | Executive Officer | 5.3 M of 5.3 M |
||
| ZS Pharma Inc | 021-152199 | Executive Officer | 0.8 M | ||
| ZS Pharma Inc | 021-129239 | Executive Officer | 1.2 M of 3.0 M |
||